HSP90AB1 and neoplasm: Although the study primarily focuses on intracellular mechanisms, the established immunogenic properties of HSP90 suggest that its inhibition may also modulate the tumor microenvironment in PRCC, potentially enhancing anti-tumor immunity alongside direct tumor cell suppression.